Inventor · disambiguated record
Erica Schlesinger
Also filed as: SCHLESINGER ERICA · SCHLESINGER ERICA B
3 granted patents·9 pending applications·1 citations·filing 2016–2025
51Inventor score
Files withREGENERON PHARMA5SERAN BIOSCIENCE LLC4BOEHRINGER INGELHEIM INT1DAY ONE BIOPHARMACEUTICALS INC1TAKEDA PHARMACEUTICALS CO1
Top patents by PatentIndex Score
12 records- 0175US11559489B2Tuning of release kinetics in hydrogelsREGENERON PHARMA·Filed 2019·Granted Jan 24, 2023·1 cites·32 claims
- 0271US2024316195A1High concentration protein formulationREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0368US12036280B2High concentration protein formulationREGENERON PHARMA·Filed 2019·Granted Jul 16, 2024·0 cites·15 claims
- 0466US12396952B2Tuning of release kinetics in hydrogelsREGENERON PHARMA·Filed 2023·Granted Aug 26, 2025·0 cites·19 claims
- 0559US2025221997A1Tyk2 inhibitor formulations and methods of making the sameTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 0659US2024226103A1Solid dispersion of a her2 inhibitorBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 0756US2025177287A1Methods and systems for injectable formulationsSERAN BIOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 0852US2024181412A1Methods and systems for spray drying temperature sensitive productsSERAN BIOSCIENCE LLC·Filed 2023·Application pending·0 cites
- 0951US2024041765A1Oral liquid suspension of pan-raf kinase inhibitorDAY ONE BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1051US2024009128A1Methods and systems for use of low-volatility solvents for spray dryingSERAN BIOSCIENCE LLC·Filed 2023·Application pending·0 cites
- 1140US2018289623A1Stable protein compositionsREGENERON PHARMA·Filed 2016·Application pending·0 cites
- 1236US2025235398A1High dosage injectable bevacizumab formulations and methodsSERAN BIOSCIENCE LLC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Erica Schlesinger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →